Importantly, we found that co-stimulation with CR Abs and RBD triggered NETosis via the SFK/PI3K/PAD4 signaling pathway, and our results suggest that blocking neutrophil activation by ACE2 or dasatinib may be a potential therapeutic strategy to prevent NETosis-induced immunothrombosis in COVID-19. Here, PADI4 is linked to COVID-19.